ZA201000853B - Pharmaceutical product comprising yeast - Google Patents

Pharmaceutical product comprising yeast

Info

Publication number
ZA201000853B
ZA201000853B ZA201000853A ZA201000853A ZA201000853B ZA 201000853 B ZA201000853 B ZA 201000853B ZA 201000853 A ZA201000853 A ZA 201000853A ZA 201000853 A ZA201000853 A ZA 201000853A ZA 201000853 B ZA201000853 B ZA 201000853B
Authority
ZA
South Africa
Prior art keywords
yeast
pharmaceutical product
pharmaceutical
product
Prior art date
Application number
ZA201000853A
Other languages
English (en)
Inventor
Bodo Asmussen
Christiane Schiller
Werner Weitschies
Gregor Garbacz
Mahmoud A Omer-Adam
Stefan Nagel
Original Assignee
Lohmann Therapie Syst Lts
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=40299087&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=ZA201000853(B) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Lohmann Therapie Syst Lts filed Critical Lohmann Therapie Syst Lts
Publication of ZA201000853B publication Critical patent/ZA201000853B/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/0002Galenical forms characterised by the drug release technique; Application systems commanded by energy
    • A61K9/0004Osmotic delivery systems; Sustained release driven by osmosis, thermal energy or gas
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06Fungi, e.g. yeasts
    • A61K36/062Ascomycota
    • A61K36/064Saccharomycetales, e.g. baker's yeast
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/2072Pills, tablets, discs, rods characterised by shape, structure or size; Tablets with holes, special break lines or identification marks; Partially coated tablets; Disintegrating flat shaped forms
    • A61K9/2086Layered tablets, e.g. bilayer tablets; Tablets of the type inert core-active coat
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00Medicinal preparations characterised by special physical form
    • A61K9/20Pills, tablets, discs, rods
    • A61K9/28Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806Coating materials
    • A61K9/2833Organic macromolecular compounds
    • A61K9/286Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Mycology (AREA)
  • Botany (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pain & Pain Management (AREA)
  • Organic Chemistry (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Medicinal Preparation (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
ZA201000853A 2007-09-01 2010-02-05 Pharmaceutical product comprising yeast ZA201000853B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE102007041588A DE102007041588A1 (de) 2007-09-01 2007-09-01 Arzneimittel mit Hefe

Publications (1)

Publication Number Publication Date
ZA201000853B true ZA201000853B (en) 2010-10-27

Family

ID=40299087

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA201000853A ZA201000853B (en) 2007-09-01 2010-02-05 Pharmaceutical product comprising yeast

Country Status (14)

Country Link
US (1) US20120027856A1 (xx)
EP (1) EP2180885B1 (xx)
JP (1) JP2010536903A (xx)
KR (1) KR101259673B1 (xx)
CN (1) CN101795676B (xx)
AU (1) AU2008316051A1 (xx)
CA (1) CA2698327C (xx)
DE (1) DE102007041588A1 (xx)
ES (1) ES2456267T3 (xx)
MX (1) MX2010002167A (xx)
NZ (1) NZ584233A (xx)
RU (1) RU2452473C2 (xx)
WO (1) WO2009052888A2 (xx)
ZA (1) ZA201000853B (xx)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE102009027938A1 (de) * 2009-07-22 2011-01-27 Universität Greifswald Orales therapeutisches System und seine Verwendung
TW201403459A (zh) * 2012-04-20 2014-01-16 Enmotus Inc 具有資料管理機制之儲存系統及操作該儲存系統之方法
WO2015190456A1 (ja) * 2014-06-10 2015-12-17 ライオン株式会社 清酒酵母を含有する錠剤
US11291683B2 (en) * 2016-04-01 2022-04-05 Access Business Group International Llc Bilayer tablets of B vitamins and process for preparing the same

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4675174A (en) * 1985-08-16 1987-06-23 Alza Corporation Veterinary dispenser delivering beneficial agent by gas power generated in situ
ATE145551T1 (de) 1989-10-02 1996-12-15 Cima Labs Inc Brausedosisform sowie verfahren zu deren verabreichung
ATE251449T1 (de) * 1999-06-14 2003-10-15 Cosmo Spa Geschmacksmaskierte orale pharmazeutische zusammensetzungen mit kontrollierter abgabe
DE10120092B4 (de) * 2001-04-25 2008-03-20 Lts Lohmann Therapie-Systeme Ag Magensaftresistente Vorrichtung zur Freisetzung von mukoadhäsiven Wirkstoffträgern und Verfahren zur Herstellung der magensaftresistenten Vorrichtung
GB0114069D0 (en) * 2001-06-08 2001-08-01 Smithkline Beecham Plc Composition
WO2002102415A1 (en) * 2001-06-18 2002-12-27 Blue Cross Laboratories Limited Gastric floating system
WO2003000112A2 (en) 2001-06-20 2003-01-03 The Governement Of The United States Of America, Represented By The Secretary, Department Of Health And Human Services Use of ribonuclease l in diagnosis of cancer
DE10224607B4 (de) * 2002-06-04 2008-03-13 Lts Lohmann Therapie-Systeme Ag Filmförmige, zerfallsfähige Zubereitungen zur Wirkstofffreisetzung und Verfahren zu deren Herstellung
CA2501345A1 (en) * 2002-10-11 2004-04-22 Depomed Development, Ltd. Gastro-retentive levodopa delivery form
US6835397B2 (en) * 2002-12-23 2004-12-28 Balchem Corporation Controlled release encapsulated bioactive substances
US20060003003A1 (en) 2004-06-28 2006-01-05 Bakker Johan A Oral sustained release formulation of tedisamil with gastric retention properties
DE102004042139B4 (de) 2004-08-31 2009-06-10 Aristocon Verwaltungs- Gmbh Perorale Darreichungsformen zur Erzielung eines Retardierungseffektes nach der Arzneimitteleinnahme mit einer Mahlzeit
US20060093592A1 (en) * 2004-10-04 2006-05-04 Nutracea Synbiotics
US7799328B2 (en) * 2004-12-23 2010-09-21 Biocodex Method for treating weight loss in patients suffering from inflammatory bowel diseases
WO2009008726A1 (en) * 2007-07-12 2009-01-15 Dsm Ip Assets B.V. Nitrate reduction by a probiotic in the presence of a heme

Also Published As

Publication number Publication date
WO2009052888A3 (de) 2009-10-15
NZ584233A (en) 2012-02-24
JP2010536903A (ja) 2010-12-02
CN101795676B (zh) 2012-11-28
RU2452473C2 (ru) 2012-06-10
CN101795676A (zh) 2010-08-04
EP2180885B1 (de) 2014-01-29
MX2010002167A (es) 2010-04-29
KR101259673B1 (ko) 2013-05-06
ES2456267T3 (es) 2014-04-21
WO2009052888A2 (de) 2009-04-30
US20120027856A1 (en) 2012-02-02
CA2698327C (en) 2013-04-30
EP2180885A2 (de) 2010-05-05
KR20100059880A (ko) 2010-06-04
AU2008316051A1 (en) 2009-04-30
DE102007041588A1 (de) 2009-03-05
CA2698327A1 (en) 2009-04-30
RU2010109523A (ru) 2011-10-20

Similar Documents

Publication Publication Date Title
GB2450753B (en) New Pharmaceutical formulation
PL2034951T3 (pl) Produkt farmaceutyczny ulegający rehydratacji
EP2018872A4 (en) PHARMACEUTICAL PRODUCT
GB2451017B (en) Construction product
GB0601498D0 (en) Product
HK1125295A1 (en) Microtablet-based pharmaceutical preparation
GB0526332D0 (en) Pharmaceutical product
GB0810615D0 (en) Novel pharmaceutical
EP2099611A4 (en) CONFIGURATION OF A FINISHED PRODUCT
GB0705775D0 (en) Product
GB0609809D0 (en) Product
GB2455897B (en) Cosmetic products
GB0618706D0 (en) Products
ZA201000853B (en) Pharmaceutical product comprising yeast
GB0810617D0 (en) Novel pharmaceutical
GB0600137D0 (en) Product
GB0717882D0 (en) Novel pharmaceutical
ZA200902856B (en) Product
AU2007905867A0 (en) Pharmaceutical process
AU2007900759A0 (en) Construction Product
GB0705030D0 (en) Pharmaceutical formulation
AU2007905870A0 (en) Pharmaceutical formulation
GB0618135D0 (en) Novel pharmaceutical
GB0804486D0 (en) Novel pharmaceutical composituons
AU2007902860A0 (en) Dispensing Pharmaceutical